Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar;42(3):E12.
doi: 10.3171/2016.11.FOCUS16348.

Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors

Affiliations

Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors

Michael D Stubblefield et al. Neurosurg Focus. 2017 Mar.

Abstract

OBJECTIVE The object of this study was to determine the percentage of high-dose (1800-2600 cGy) single-fraction stereotactic radiosurgery (SF-SRS) treatments to the spine that result in peripheral nervous system (PNS) injury. METHODS All patients treated with SF-SRS for primary or metastatic spine tumors between January 2004 and May 2013 and referred to the Rehabilitation Medicine Service for evaluation and treatment of neuromuscular, musculoskeletal, or functional impairments or pain were retrospectively identified. RESULTS Five hundred fifty-seven SF-SRS treatments in 447 patients resulted in 14 PNS injuries in 13 patients. All injures resulted from SF-SRS delivered to the cervical or lumbosacral spine at 2400 cGy. The overall percentage of SF-SRS treatments resulting in PNS injury was 2.5%, increasing to 4.5% when the thoracic spine was excluded from analysis. The median time to symptom onset following SF-SRS was 10 months (range 4-32 months). The plexus (cervical, brachial, and/or lumbosacral) was affected clinically and/or electrophysiologically in 12 (86%) of 14 cases, the nerve root in 2 (14%) of 14, and both in 6 (43%) of 14 cases. All patients experienced pain and most (93%) developed weakness. Peripheral nervous system injuries were CTCAE Grade 1 in 14% of cases, 2 in 64%, and 3 in 21%. No dose relationship between SF-SRS dose and PNS injury was detected. CONCLUSIONS Single-fraction SRS to the spine can result in PNS injury with major implications for function and quality of life.

Keywords: CTCAE = Common Terminology Criteria for Adverse Events; DRG = dorsal root ganglion; EGFR = epidermal growth factor; EMG = electromyography; GTV = gross tumor volume; PNS = peripheral nervous system; PTV = planning treatment volume; SF-SRS = single-fraction stereotactic radiosurgery; VEGF = vascular endothelial growth factor; complications; peripheral nerve; radiosurgery; spine.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Percentage of PNS injuries in all patients treated with SF-SRS (18–26 Gy) by spinal level.
FIG. 2
FIG. 2
Time to PNS injury (in years since SF-SRS) using competing risk methods—18 to 26 Gy (557 treatments).

Similar articles

Cited by

References

    1. Balagamwala EH, Angelov L, Koyfman SA, Suh JH, Reddy CA, Djemil T, et al. Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine. 2012;17:556–564. - PubMed
    1. Collen C, Ampe B, Gevaert T, Moens M, Linthout N, De Ridder M, et al. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys. 2011;81:e503–e509. - PubMed
    1. Cox BW, Jackson A, Hunt M, Bilsky M, Yamada Y. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83:e661–e667. - PMC - PubMed
    1. Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereo-tactic radiosurgery. Int J Radiat Oncol Biol Phys. 2012;83:e597–e605. - PubMed
    1. Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, et al. Validity and reliability of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) JAMA Oncol. 2015;1:1051–1059. - PMC - PubMed